CN104922174A - Traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting liver and kidney - Google Patents
Traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting liver and kidney Download PDFInfo
- Publication number
- CN104922174A CN104922174A CN201510344171.0A CN201510344171A CN104922174A CN 104922174 A CN104922174 A CN 104922174A CN 201510344171 A CN201510344171 A CN 201510344171A CN 104922174 A CN104922174 A CN 104922174A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- selenium
- radiotherapy
- kidney
- chemotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
A traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting the liver and the kidney comprises 20%-40% of selenium enrichment cordyceps militaris, 15%-25% of pseudo ginseng, 15%-25% of American ginseng and 10%-50% of isomaltulose, and each gram of selenium enrichment cordyceps militaris comprises 5-400 microgrammes of selenium.
Description
Technical field
The present invention is the Chinese medicine formula that a kind of anti-cancer and cancer-preventing improves chemoradiotherapy tolerance degree, is specifically related to a kind of Chinese medicine formula utilizing the dialectical theory of Chinese medicine to draw, belongs to tcm field.
Background technology
At present, Chinese medicine mostly be blood circulation promoting and blood stasis dispelling in cancer, the theory compatibility gained formula for the treatment of the poisonous disease with poisonous drugs, institute's magistral medicines generally has very large toxicity to human body, to a body huge strike beyond doubt for originally weak cancer patient.And normal in addition chemotherapy or the radiotherapy after the procedure of doctor trained in Western medicine, patient has been difficult to the toxic insult of bearing, radiotherapy after standing the wound of performing the operation, and really stands the toxic and side effects of incessantly change, radiotherapy and yields that there are plenty of such people, cause cancer cure rate low, majority just recurs soon loses one's life.The invention provides a kind of self anti-cancer ability of enhancing; the liver protecting is beneficial to removing toxic substances; protection kidney is beneficial to toxin expelling; give full play to the Chinese medicine formula of human body self-regeneration function; change at present, doctor trained in Western medicine fights the enemy 1,000 from the situation of damaging 800 for cancer, for the tolerance degree of anti-cancer and cancer-preventing, raisingizations, radiotherapy, the quality of life of raising patient, life-saving make due contribution.
Summary of the invention
Main purpose of the present invention is self anti-cancer ability strengthening patient, the outstanding phase is the various cancer antigenic indexs at reduction initial stage, in cancer, the preoperative body constitution fast lifting in late period, postoperative consolidating is kept fit, and resisting, radiotherapy toxicity, strengthening the tolerance of human body to chemoradiotherapy has larger benifit effect, simultaneously, the present invention significantly protects the liver in addition and protects kidney effect, has good auxiliary curative effect for hypertension, diabetes, hyperlipidemia, impaired renal function, albuminuria.Formula of the present invention is made up of selenium-enriched cordceps militaris, Radix Notoginseng, Radix Panacis Quinquefolii and isomaltulose, wherein selenium-enriched cordceps militaris accounts for gross weight 20% to 40%, Radix Notoginseng accounts for gross weight 15% to 25%, Radix Panacis Quinquefolii accounts for gross weight 15% to 25%, isomaltulose accounts for gross weight 10% to 50%, wherein selenium-enriched cordceps militaris every gram selenium content be 5 to 400 micrograms/gram.Take for convenience, can according to the above ratio selenium-enriched cordceps militaris, Radix Notoginseng, Radix Panacis Quinquefolii, isomaltulose be ground and make powder, or make capsule, or make granule, or make tablet.
In above-mentioned formula, selenium-enriched cordceps militaris has three aspect effects, the first provides enough organic seleniums for human body, it is the core material of human body synthesizing glutathion peroxidase, positive effect is had to anti-cancer and cancer-preventing, the accumulation of selenium in liver, kidney, is conducive to the own health strengthening liver, kidney, thus strengthens their detoxication and toxicant eliminating function ability, it two is selenium-enriched cordceps militaris lung benefiting profit kidneys, has very large benefit effect to promoting renal function; It three is that selenium-enriched cordceps militaris contains a large amount of cordycepins, has stronger inhibitory action to cancerous cell.Selenium-enriched cordceps militaris is the core ingredient of this formula, and its function is that common Cordyceps or Cordyceps militaris (L.) Link. are irreplaceable.Radix Notoginseng in formula, one is in order to promoting blood circulation to remove blood stasis, and two is in order to anticancer, the effect of Radix Panacis Quinquefolii is enriching yin boost qi, and isomaltulose only just can be decomposed in human small intestine, and it is the food of human body probiotic bacteria, the long-term edible amount reproduction being beneficial to enteral probiotic bacteria, thus improve the immunity of human body.
Specific embodiment
Get selenium content be 100 micrograms/gram, dry sterilization after selenium-enriched cordceps militaris 2 kilograms, dry the Radix Notoginseng 2 kilograms after sterilization, dry the Radix Panacis Quinquefolii 2 kilograms after sterilization, after wearing into 100 order fine powders, fully mix with 4 kilograms of isomaltuloses, then by the above-mentioned mixed powder subpackage of often wrapping 10 grams, can be made into powder 1000 of the present invention and wrap.
Claims (3)
1. anti-cancer and cancer-preventing raising chemoradiotherapy tolerance degree protects the liver the Chinese medicine formula protecting kidney, it is characterized in that: be made up of selenium-enriched cordceps militaris, Radix Notoginseng, Radix Panacis Quinquefolii and isomaltulose.
2. Chinese medicine formula according to claim 1, is characterized in that: selenium-enriched cordceps militaris accounts for gross weight 20% to 40%, Radix Notoginseng accounts for gross weight 15% to 25%, and Radix Panacis Quinquefolii accounts for gross weight 15% to 25%, and isomaltulose accounts for gross weight 10% to 50%.
3. Chinese medicine formula according to claim 1, is characterized in that: selenium-enriched cordceps militaris every gram selenium content be 5 to 400 micrograms/gram.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510344171.0A CN104922174A (en) | 2015-06-22 | 2015-06-22 | Traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting liver and kidney |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510344171.0A CN104922174A (en) | 2015-06-22 | 2015-06-22 | Traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting liver and kidney |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104922174A true CN104922174A (en) | 2015-09-23 |
Family
ID=54109829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510344171.0A Pending CN104922174A (en) | 2015-06-22 | 2015-06-22 | Traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting liver and kidney |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104922174A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106820166A (en) * | 2017-01-17 | 2017-06-13 | 恩施硒域传奇健康管理有限公司 | A kind of full nutrition formula food suitable for nephrotic |
CN110101764A (en) * | 2019-06-11 | 2019-08-09 | 武汉圣润生物科技有限公司 | A kind of composition and preparation method thereof of adjuvant therapy treatment |
CN113908180A (en) * | 2021-11-13 | 2022-01-11 | 广东暨创硒源纳米研究院有限公司 | Application of nano-selenium cordyceps militaris aqueous extract in reducing radiotherapy injury and protective agent thereof |
WO2023082217A1 (en) * | 2021-11-13 | 2023-05-19 | 广东暨创硒源纳米研究院有限公司 | Use of nano-selenium cordyceps militaris aqueous extract in reducing radiotherapy injury and protective agent |
-
2015
- 2015-06-22 CN CN201510344171.0A patent/CN104922174A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106820166A (en) * | 2017-01-17 | 2017-06-13 | 恩施硒域传奇健康管理有限公司 | A kind of full nutrition formula food suitable for nephrotic |
CN110101764A (en) * | 2019-06-11 | 2019-08-09 | 武汉圣润生物科技有限公司 | A kind of composition and preparation method thereof of adjuvant therapy treatment |
CN113908180A (en) * | 2021-11-13 | 2022-01-11 | 广东暨创硒源纳米研究院有限公司 | Application of nano-selenium cordyceps militaris aqueous extract in reducing radiotherapy injury and protective agent thereof |
WO2023082217A1 (en) * | 2021-11-13 | 2023-05-19 | 广东暨创硒源纳米研究院有限公司 | Use of nano-selenium cordyceps militaris aqueous extract in reducing radiotherapy injury and protective agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rana et al. | Living life the natural way–Wheatgrass and Health | |
CN104922174A (en) | Traditional Chinese medicine prescription capable of fighting and defending cancers, increasing tolerance degree to chemotherapy and radiotherapy and protecting liver and kidney | |
KR20200107939A (en) | Compositions and methods for controlling cholesterol, glucose and microbiome | |
CN104825681A (en) | Traditional Chinese medicine composition for improving alimentary anemia | |
CN105031301A (en) | Anti-tumor traditional Chinese medicine composition and preparation method thereof | |
US20240123014A1 (en) | Natural combination products and methods for regulation of kidney and excretory system function | |
CN103417735A (en) | Traditional Chinese medicine for treating obesity | |
CN105748947A (en) | Dendrobium officinale compound capsule and preparation method thereof | |
CN101766666A (en) | Chinese medicament for treating cardiovascular and cerebrovascular diseases | |
CN102406778B (en) | Traditional Chinese medicine composition for treating Alzheimer type dementia and preparation method thereof | |
CN106038702B (en) | Antifatigue composition and its preparation method and application | |
CN104738273A (en) | Formula of medicinal and edible health tea conducive to improvement of organism immunity | |
US20180169071A1 (en) | Nutritional supplement composition | |
CN109125370A (en) | A kind of middle pharmaceutical formulation for treating body odour | |
CN102949681B (en) | Composition for preventing or treating colds, and its preparation method | |
CN104940666A (en) | Pharmaceutical composition having anti-hypoxia effect and preparation method | |
CN104887834A (en) | Matrine containing composition for treatment or prevention of mammal cancer and other diseases | |
CN104411319A (en) | Hawthorn and phytosterols and their effect on metabolic disorders | |
CN103585330B (en) | A kind of Chinese medicine composition for cutaneous fungal infection and preparation method thereof | |
CN105832946A (en) | Medicine for treating human cancer and production method thereof | |
CN103800342B (en) | Composition with reduced toxicity of cucurbitacin and medical application thereof | |
CN104758306A (en) | Application and medicine of 20(R)-ginsenoside Rg3 to preparing medicine for remitting and/or treating gastric ulcer | |
CN103330739B (en) | Traditional Chinese medicine compound for improving symptom of diabetes | |
CN103585428A (en) | Traditional Chinese medicine preparation for treating diabetes | |
CN102327539B (en) | Externally-used medicine for curing stomachache |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150923 |
|
WD01 | Invention patent application deemed withdrawn after publication |